0
0
Read Time:11 Second
It is this immune resistance that has been the main feature of JN.1, a reason why it now accounts for nearly 38% of all sequences submitted to the global GISAID repository in the week ending December 10.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %